Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
Indian markets decline amidst US bond market sell-off and rising yields
23/05/2025
Harvard’s ability to enrol international students halted by Trump administration
22/05/2025
Elon Musk : Politics failed him. Can business redeem him ?
22/05/2025
Goldman Sachs buys shares worth Rs 50 crore in this smallcap stock via block deal
22/05/2025
RBI’s March forex buys hit 5-year high to boost banking liquidity
22/05/2025
Ashok Hinduja backs IndusInd Bank board amid fraud concerns, calls it a 'new dawn' for the lender
22/05/2025
